Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • News
  • Offerings

Amylyx Pharmaceuticals Announces Launch Of Public Offering Of 6M Shares Of Common Stock

By Benzinga Newsdesk
October 4, 4:24 PM
Amylyx Pharmaceuticals, Inc. ("Amylyx") today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S.

AMLX

Read More
1 minute read
  • News
  • Offerings
  • Tech

Playtika Reveals Preliminary Results Of Oversubscribed Tender Offer

By Anusuya Lahiri
October 4, 1:06 PM
Mobile gaming entertainment and technology company Playtika Holding Corp (NASDAQ:PLTK) announced the preliminary results of its August 29 tender offer to purchase…

PLTK

Read More
5 minute read
  • News
  • Offerings

Zealand Pharma Announces Directed Issue And Private Placement Of ~4.5M New Shares

By Benzinga Newsdesk
October 4, 11:09 AM
Company announcement – No. 43 / 2022 Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE

ZEAL

Read More
2 minute read
  • News
  • Offerings

XORTX Announces $5M Public Offering

By Bill Haddad
October 4, 8:31 AM
XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat

TSXV:XRTX

Read More
1 minute read
  • News
  • Offerings
  • Small Cap

Rocket Pharmaceuticals Priced 6.*M Share Public Offering of Common Stock @ $14.75/Share

By Charles Gross
October 4, 4:43 AM
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 6,800,000 shares of its common stock at a public offering price of $14.75 per share.

RCKT

Read More
1 minute read
  • News
  • Offerings

Salem Media Group Reports Additional Offering Of 1M Shares Of Common Stock By Selling Stockholders

By Michael Horton
October 3, 5:29 PM
-Reuters

SALM

Read More
1 minute read
  • News
  • Offerings

Salem Media Group Files For $40M Mixed-Securities Shelf Offering

By Michael Horton
October 3, 5:26 PM
-Reuters

SALM

Read More
1 minute read
  • News
  • Offerings

Calyxt Says May Offer, Sell Up To 15.6M Shares Of Common Stock From Time To Time

By Michael Horton
October 3, 5:21 PM
-Reuters

CLXT

Read More
2 minute read
  • News
  • Offerings

Rocket Pharmaceuticals Announces Proposed Public Offering Of $100M Of Shares Of Its Common Stock

By Benzinga Newsdesk
October 3, 4:43 PM
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of investigational genetic therapies for rare childhood disorders with high

RCKT

Read More
2 minute read
  • Buybacks
  • Commodities
  • Dividends
  • Earnings
  • General
  • Health Care
  • Hedge Funds
  • Large Cap
  • Long Ideas
  • Management
  • Markets
  • News
  • Offerings
  • Retail Sales
  • Trading Ideas

Check Out These Two Dividend Stocks Dan Loeb Holds For Steady Gains

By Robert Kuczmarski
October 2, 4:32 PM
Dan Loeb’s Third Point Management has earned annualized returns of 15.7% since its inception in 1995 through December 2016.

DIS

Posts pagination

Previous 1 … 139 140 141 … 166 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service